Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4330-4340
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4330
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4330
Ref. | SMO | SHH | PTCH | Gli1 | Clinical correlation |
Sicklick et al[52], 2006 | 42.90% (3-fold higher than normal tissues) | 50% (3- to 4-fold higher than normal tissues) | Tumour size | ||
21.4% (8- to 9-fold higher than normal tissues) | |||||
Huang et al[53], 2006 | 59% positive tumours | 56% positive tumours | 72% positive tumours | Tumour size | |
Che et al[59], 2012 | 32.61% positive tumours | 60.87% positive tumours | 50% positive tumours | 54.35% positive tumours | Gli1 with disease-free survival (DFS) and overall survival (OS) |
Dugum et al[54], 2016 | 100% tumoural and surrounding tissue | 100% tumoural and surrounding tissue, with higher expression in tumour tissue | 100% tumoural and surrounding tissue | Tendency to correlation with HCC recurrence after liver transplantation |
- Citation: Della Corte CM, Viscardi G, Papaccio F, Esposito G, Martini G, Ciardiello D, Martinelli E, Ciardiello F, Morgillo F. Implication of the Hedgehog pathway in hepatocellular carcinoma. World J Gastroenterol 2017; 23(24): 4330-4340
- URL: https://www.wjgnet.com/1007-9327/full/v23/i24/4330.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i24.4330